Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony Academic Article uri icon

Overview

MeSH Major

  • Amphotericin B
  • Anti-Bacterial Agents
  • Leishmaniasis, Visceral

abstract

  • Short-course therapy with low-dose amphotericin B lipid complex is effective for visceral leishmaniasis and is an important therapeutic alternative in the management of this serious intracellular protozoal infection.

publication date

  • July 15, 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9230003

Additional Document Info

start page

  • 133

end page

  • 7

volume

  • 127

number

  • 2